Recently, understanding the molecular pathogenesis of malignant lymphomas has led to improvement in the diagnostic precision and to the identification of a variety of molecular therapeutic targets. In addition, new drugs have been approved in the US and Europe, resulting in changes in the standard of care of several types of lymphoid malignancies. Comprehensive in scope and developed by a team of internationally renowned authors, "Lymphoma: Diagnosis and Treatment" provides a timely update on the most important advances in the biology, diagnosis, and therapy of lymphomas. As part of the Current Clinical Oncology series, "Lymphoma: Diagnosis and Treatment" will be of value to medical oncologists, hematologists, radiation oncologists, and all physicians involved in the care of patients with lymphoid malignancies.

The Handbook of Lymphoma is an in-depth and comprehensive guide to the diagnosis, staging, treatment, and management of patients with the disease. The Handbook aims to provide healthcare professionals with an informative and up-to-date guide to the latest developments in the treatment of patients with both Hodgkin and non-Hodgkin lymphoma. Lymphoma is a cancer of the lymphatic system and, as with other cancers, is a disease of the body's cells. Usually, cells divide in the body in an orderly and controlled manner, however when this process gets out of control and the cells carry on dividing in an abnormal manner a tumor can form known as lymphoma in one or more groups of lymph nodes. This field has seen increasing development in the available options for treating patients with lymphoma particularly in the recent emergence and approval of targeted therapies. In this clinically focused Handbook, the authors address these advances by looking at treatment recommendations for both Hodgkin and non-Hodgkin lymphoma, and also making suggestions on the future outlook for patients with this disease. This Handbook is an invaluable and educational source of topical information for all medical and healthcare professionals with an interest in lymphoma.

Recently, understanding the molecular pathogenesis of malignant lymphomas has led to improvement in the diagnostic precision and to the identification of a variety of molecular therapeutic targets. In addition, new drugs have been approved in the US and Europe, resulting in changes in the standard of care of several types of lymphoid malignancies. Comprehensive in scope and developed by a team of internationally renowned authors, Lymphoma: Diagnosis and Treatment provides a timely update on the most important advances in the biology, diagnosis, and therapy of lymphomas. As part of the Current Clinical Oncology series, Lymphoma: Diagnosis and Treatment will be of value to medical oncologists, hematologists, radiation oncologists, and all physicians involved in the care of patients with lymphoid malignancies.

This book examines in detail the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the management appropriate in special clinical circumstances, including in the elderly, pregnant women, and those with lymphocyte-predominant disease. Careful attention is devoted to the emerging individually tailored treatment strategies that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The second edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by the key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.